Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More
ZOTA HEALTH CARE ADCOCK INGRAM |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ZOTA HEALTH CARE Mar-23 |
ADCOCK INGRAM Jun-14 |
ZOTA HEALTH CARE/ ADCOCK INGRAM |
5-Yr Chart Click to enlarge
|
||
High | Rs | 378 | 315 | - | |
Low | Rs | 225 | 228 | - | |
Sales per share (Unadj.) | Rs | 55.6 | 93.8 | - | |
Earnings per share (Unadj.) | Rs | -2.3 | -23.6 | - | |
Cash flow per share (Unadj.) | Rs | 2.5 | -19.6 | - | |
Dividends per share (Unadj.) | Rs | 1.00 | 0 | - | |
Avg Dividend yield | % | 0.3 | 0 | - | |
Book value per share (Unadj.) | Rs | 31.9 | 73.6 | - | |
Shares outstanding (eoy) | m | 25.16 | 168.78 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 5.4 | 2.9 | 187.3% | |
Avg P/E ratio | x | -131.3 | -11.5 | 1,143.6% | |
P/CF ratio (eoy) | x | 122.6 | -13.9 | -884.7% | |
Price / Book Value ratio | x | 9.4 | 3.7 | 255.9% | |
Dividend payout | % | -43.6 | 0 | - | |
Avg Mkt Cap | Rs m | 7,581 | 45,814 | 16.5% | |
No. of employees | `000 | NA | 4.3 | 0.0% | |
Total wages/salary | Rs m | 121 | 2,875 | 4.2% | |
Avg. sales/employee | Rs Th | 0 | 3,688.3 | - | |
Avg. wages/employee | Rs Th | 0 | 669.8 | - | |
Avg. net profit/employee | Rs Th | 0 | -929.4 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 1,399 | 15,834 | 8.8% | |
Other income | Rs m | 26 | 111 | 23.7% | |
Total revenues | Rs m | 1,425 | 15,945 | 8.9% | |
Gross profit | Rs m | 72 | -2,744 | -2.6% | |
Depreciation | Rs m | 120 | 683 | 17.5% | |
Interest | Rs m | 26 | 429 | 6.0% | |
Profit before tax | Rs m | -47 | -3,745 | 1.3% | |
Minority Interest | Rs m | 0 | -10 | -0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 11 | 234 | 4.6% | |
Profit after tax | Rs m | -58 | -3,990 | 1.4% | |
Gross profit margin | % | 5.2 | -17.3 | -29.7% | |
Effective tax rate | % | -23.1 | -6.2 | 369.0% | |
Net profit margin | % | -4.1 | -25.2 | 16.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 842 | 11,597 | 7.3% | |
Current liabilities | Rs m | 405 | 6,525 | 6.2% | |
Net working cap to sales | % | 31.2 | 32.0 | 97.4% | |
Current ratio | x | 2.1 | 1.8 | 116.9% | |
Inventory Days | Days | 20 | 111 | 18.0% | |
Debtors Days | Days | 726 | 124 | 585.9% | |
Net fixed assets | Rs m | 728 | 6,760 | 10.8% | |
Share capital | Rs m | 252 | 74 | 342.2% | |
Net worth | Rs m | 804 | 12,428 | 6.5% | |
Long term debt | Rs m | 0 | 4,367 | 0.0% | |
Total assets | Rs m | 1,570 | 23,477 | 6.7% | |
Interest coverage | x | -0.8 | -7.7 | 10.7% | |
Debt to equity ratio | x | 0 | 0.4 | 0.0% | |
Sales to assets ratio | x | 0.9 | 0.7 | 132.1% | |
Return on assets | % | -2.0 | -15.2 | 13.5% | |
Return on equity | % | -7.2 | -32.1 | 22.4% | |
Return on capital | % | -2.6 | -19.8 | 13.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -20 | 1,352 | -1.5% | |
From Investments | Rs m | 147 | -415 | -35.4% | |
From Financial Activity | Rs m | -139 | 3,964 | -3.5% | |
Net Cashflow | Rs m | -12 | 4,900 | -0.2% |
Compare ZOTA HEALTH CARE With: MYLAN (US) ACTAVIS (US) TEVA PHARMA (Israel)
Compare ZOTA HEALTH CARE With: WOCKHARDT SMS PHARMA NORRIS MEDICINES THEMIS MEDICARE SYSCHEM (I).
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.